The election expands the AmerisourceBergen board from eight to nine members.

Dr. Henney currently is Senior Scholar in Residence at the Association of
Academic Health Centers in Washington, D.C. Prior to this appointment, she was
Commissioner of the Food and Drug Administration (FDA) from 1998 through 2001.
She was also Deputy Commissioner for Operations at the FDA from 1992 to 1994.

She is a medical oncologist and has held several posts at the National Cancer
Institute, including Deputy Director from 1980 to 1995. Her past academic
positions include Vice President for Health Sciences at the University of New
Mexico and Vice Chancellor of Health Programs and Policy at the University of
Kansas.

Dr. Henney is a frequent lecturer on a variety of healthcare subjects, and has
received many honors and awards in her field.

Robert E. Martini, Chairman of the Board of Directors of AmerisourceBergen,
said, "Dr. Henney brings considerable expertise and experience in healthcare.
The Company and its shareholders are fortunate to have the multiple talents of
Dr. Henney to help mold the future direction of AmerisourceBergen."

R. David Yost, AmerisourceBergen's President and Chief Executive Officer, added,
"Dr. Henney will be a great addition to the Board. I look forward to working
with her as we build AmerisourceBergen."

Dr. Henney received her Bachelor of Science degree from Manchester College,
North Manchester, Indiana, and her Doctor of Medicine degree from Indiana
University School of Medicine. Her graduate medical education includes a
Fellowship in Medical Oncology at the Department of Developmental Therapeutics
at M.D. Anderson Hospital and Tumor Institute in Houston, Texas.

About AmerisourceBergen

AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in
the United States dedicated solely to the pharmaceutical supply chain. It is the
leading distributor of pharmaceutical products and services to the hospital
systems/acute care market, alternative care providers, independent community
pharmacies, and regional chains.

The company is also a leader in the institutional pharmacy marketplace. With
approximately $35 billion in annualized operating revenues, AmerisourceBergen is
headquartered in Valley Forge, PA, and employs more than 13,000 people serving
over 25,000 customers.

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel.